Envestnet Asset Management Inc. Has $297.51 Million Position in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Envestnet Asset Management Inc. cut its holdings in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 8.3% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 569,986 shares of the medical equipment provider’s stock after selling 51,449 shares during the period. Envestnet Asset Management Inc. owned 0.16% of Intuitive Surgical worth $297,510,000 as of its most recent filing with the SEC.

Several other large investors have also made changes to their positions in ISRG. M.E. Allison & CO. Inc. acquired a new position in shares of Intuitive Surgical during the fourth quarter worth approximately $449,000. Seilern Investment Management Ltd acquired a new position in Intuitive Surgical during the 4th quarter valued at $82,517,000. Sycomore Asset Management raised its stake in Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock valued at $9,214,000 after purchasing an additional 4,079 shares during the last quarter. Exome Asset Management LLC boosted its holdings in Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after purchasing an additional 1,069 shares during the period. Finally, China Universal Asset Management Co. Ltd. grew its position in Intuitive Surgical by 5.6% in the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after purchasing an additional 525 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Wall Street Analyst Weigh In

A number of brokerages have recently commented on ISRG. Barclays upped their price objective on shares of Intuitive Surgical from $610.00 to $674.00 in a research report on Monday, January 27th. Erste Group Bank downgraded Intuitive Surgical from a “strong-buy” rating to a “hold” rating in a research report on Monday, March 17th. Evercore ISI boosted their price objective on Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. JPMorgan Chase & Co. raised their target price on Intuitive Surgical from $575.00 to $675.00 and gave the stock an “overweight” rating in a research report on Friday, January 24th. Finally, Truist Financial decreased their price target on shares of Intuitive Surgical from $666.00 to $605.00 and set a “buy” rating on the stock in a research note on Monday, March 17th. One equities research analyst has rated the stock with a sell rating, five have assigned a hold rating and fifteen have assigned a buy rating to the company’s stock. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and an average price target of $611.86.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 11,545 shares of the stock in a transaction on Thursday, March 13th. The shares were sold at an average price of $499.22, for a total value of $5,763,494.90. Following the sale, the executive vice president now directly owns 5,224 shares in the company, valued at approximately $2,607,925.28. This trade represents a 68.85 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, CFO Jamie Samath sold 94 shares of Intuitive Surgical stock in a transaction on Wednesday, January 29th. The stock was sold at an average price of $571.11, for a total transaction of $53,684.34. Following the transaction, the chief financial officer now directly owns 2,630 shares in the company, valued at approximately $1,502,019.30. This represents a 3.45 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 33,754 shares of company stock valued at $17,691,621. 0.70% of the stock is currently owned by insiders.

Intuitive Surgical Trading Down 8.7 %

Shares of ISRG stock opened at $451.58 on Friday. The firm’s 50 day moving average is $545.18 and its 200-day moving average is $532.64. The firm has a market capitalization of $160.84 billion, a price-to-earnings ratio of 70.45, a PEG ratio of 5.85 and a beta of 1.55. Intuitive Surgical, Inc. has a 1 year low of $364.17 and a 1 year high of $616.00.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.